June 1 - 2, 2026
Renaissance Seaport District, Boston, MA
I have over 20 years of leadership experience launching new and innovative diagnostic and software products that have accelerated the adoption of precision medicine. Over this time I’ve gained a deep understanding of the genetic and genomic needs of cancer patients and how the healthcare system workflow can either hinder or help them gain access to these valuable insights that could save or extend lives. I’ve used my experience to create new products and strategies to solve challenges associated with patient access to precision medicine. I earned a Certificate of Specialization in Business Strategy from Harvard Business School Online by researching the immense potential of genetics to transform healthcare. My work focused on how genetics can improve treatment outcomes, enable early disease detection and cures, eliminate chronic diseases, and prevent illnesses for future generations. I’m also an IFC-certified leadership and executive coach, helping companies in the precision medicine space drive adoption of innovative products and services faster, while advancing health equity across the healthcare system.
The convergence of three powerful market forces is turning precision medicine into a mainstream conversation. AI is transforming real-world data into actionable insights at point-of-care. Empowered patients are reshaping demand for precision medicine, and global political pressure is accelerating investment for greater patient access to genomics, bringing cure and prevention for cancer and rare diseases within reach in our generation.
Check out the incredible speaker line-up to see who will be joining Rome.
Download The Latest Agenda